Eplerenone attenuates pulse wave reflection in chronic kidney disease stage 3-4--a randomized controlled study

Lene Boesby, Thomas Elung-Jensen, Svend Strandgaard, Anne-Lise Kamper

39 Citationer (Scopus)

Abstract

Patients with chronic kidney disease (CKD) have high cardiovascular mortality and morbidity associated with increased arterial stiffness. Plasma aldosterone levels are increased in CKD, and aldosterone has been found to increase vascular inflammation and fibrosis. It was hypothesized that aldosterone receptor inhibition with eplerenone could reduce arterial stiffness in CKD stage 3-4.
OriginalsprogEngelsk
TidsskriftP L o S One
Vol/bind8
Udgave nummer5
Sider (fra-til)e64549
ISSN1932-6203
DOI
StatusUdgivet - 2013

Fingeraftryk

Dyk ned i forskningsemnerne om 'Eplerenone attenuates pulse wave reflection in chronic kidney disease stage 3-4--a randomized controlled study'. Sammen danner de et unikt fingeraftryk.

Citationsformater